In Differentiated Thyroid Cancer, an Incomplete Structural Response to Therapy Is Associated with Significantly Worse Clinical Outcomes Than Only an Incomplete Thyroglobulin Response-Reference-Cited by-同舟云学术

In Differentiated Thyroid Cancer, an Incomplete Structural Response to Therapy Is Associated with Significantly Worse Clinical Outcomes Than Only an Incomplete Thyroglobulin Response

Published:2011-12 Issue:12 Volume:21 Page:1317-1322
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Vaisman Fernanda¹,Tala Hernan²,Grewal Ravinder³,Tuttle R. Michael⁴

Affiliation:

1. Endocrinology Service, Universidade Federal do Rio de Janeiro and Instituto Nacional do Cancer, Rio de Janeiro, Brazil.

2. Endocrinology Service, Clínica Alemana/Universidad del Desarrollo, Santiago, Chile.

3. Nuclear Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, New York.

4. Endocrinology Service, Memorial Sloan-Kettering Cancer Center, New York, New York.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2011.0232

Reference14 articles.

1. Prognostic importance of histologic grading in papillary thyroid carcinoma

2. Natural History, Treatment, and Course of Papillary Thyroid Carcinoma*

3. Classification of papillary cancer of the thyroid based on prognosis

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges in treating radioiodine-refractory thyroid cancer: a global perspective with a focus on developing nations in Latin America;Endocrine;2024-07-30

2. Clinicopathological features affecting the efficacy in 131I ablation therapy of papillary thyroid carcinoma with lymph node metastasis;Frontiers in Endocrinology;2024-07-17

3. Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part II. Follow-up Surveillance after Initial Treatment 2024;International Journal of Thyroidology;2024-05-30

4. “Watch and wait” approach in the treatment of advanced radioiodine refractory differentiated thyroid cancer: a study of barriers and drivers of use;Head and Neck Tumors (HNT);2024-04-06

5. Chapter 6: Risk Stratification and Surveillance in Differentiated Thyroid Cancers;Journal of Head & Neck Physicians and Surgeons;2024-01